Unknown

Dataset Information

0

Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis.

ABSTRACT: Mutations in genes such as transglutaminase-1 (TGM1), which are responsible for the formation and normal functioning of a lipid barrier, lead to the development of autosomal recessive congenital ichthyosis (ARCI). ARCIs are characterized by varying degrees of hyperkeratosis and the presence of scales on the body surface since birth. The quality of life of patients is often significantly affected, and in order to alleviate the manifestations of the disease, symptomatic therapy with moisturizers, keratolytics, retinoids and other cosmetic substances is often used to improve the condition of the patients' skin. Graft transplantation is commonly used to correct defects of the eye. However, these approaches offer symptomatic treatment that does not restore the lost protein function or provide a long-term skin barrier. Gene and cell therapies are evolving as promising therapy for ARCIs that can correct the functional activity of altered proteins. However, these approaches are still at an early stage of development. This review discusses current studies of gene and cell therapy approaches for various types of ichthyosis and their further prospects for patient treatment.

SUBMITTER: Chulpanova DS 

PROVIDER: S-EPMC8910354 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis.

Chulpanova Daria S DS   Shaimardanova Alisa A AA   Ponomarev Aleksei S AS   Elsheikh Somaia S   Rizvanov Albert A AA   Solovyeva Valeriya V VV  

International journal of molecular sciences 20220224 5

Mutations in genes such as transglutaminase-1 (<i>TGM1</i>), which are responsible for the formation and normal functioning of a lipid barrier, lead to the development of autosomal recessive congenital ichthyosis (ARCI). ARCIs are characterized by varying degrees of hyperkeratosis and the presence of scales on the body surface since birth. The quality of life of patients is often significantly affected, and in order to alleviate the manifestations of the disease, symptomatic therapy with moistur  ...[more]

Similar Datasets

Unknown PNPLA1-Mediated Acylceramide Biosynthesis and Autosomal Recessive Congenital Ichthyosis.
| S-EPMC9332298 | biostudies-literature
Unknown Mutations in SULT2B1 Cause Autosomal-Recessive Congenital Ichthyosis in Humans.
| S-EPMC5473727 | biostudies-literature
Unknown Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans.
| S-EPMC3675029 | biostudies-literature
Unknown Mutations in transglutaminase 1 gene in autosomal recessive congenital ichthyosis in Egyptian families.
| S-EPMC3839340 | biostudies-other
Proteomics Proteomic Manifestations of Genetic Defects in Autosomal Recessive Congenital Ichthyosis
2018-08-17 | MSV000082828 | MassIVE
Unknown Phenotypic spectrum of autosomal recessive congenital ichthyosis due to PNPLA1 mutation.
| S-EPMC5522355 | biostudies-literature
Unknown A novel mutation in the transglutaminase-1 gene in an autosomal recessive congenital ichthyosis patient.
| S-EPMC4142565 | biostudies-literature
Unknown Autosomal recessive congenital ichthyosis: CERS3 mutations identified by a next generation sequencing panel targeting ichthyosis genes.
| S-EPMC5643971 | biostudies-literature
Unknown Novel compound heterozygous mutations in the CYP4F22 gene in a patient with autosomal recessive congenital ichthyosis.
| S-EPMC8645175 | biostudies-literature
Transcriptomics Tofacitinib reduces skin inflammation in a patient with severe autosomal recessive congenital ichthyosis
2023-04-03 | GSE228449 | GEO